303 results

• Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named

  March 27, 2025

  Irvin Jackson

  The federal judge overseeing all Valsartan lawsuits has approved a process that requires plaintiffs to establish they used specific versions of the recalled pills made by each manufacturer named as a defendant in their complaint.

• High Blood Pressure Risks Linked to Some Antidepressants: Study

  March 12, 2025

  Martha Garcia

  A link has been found between certain antidepressants and an increased risk of high blood pressure, which could lead to heart attacks and strokes.

• Ultra-Processed Food Warning Labels Could Reduce Consumption in Children: Study

  March 11, 2025

  Michael Adams

  New research indicates that a different method for labeling caloric intakes could lead to slightly less ultra-processed food consumption by school-aged children.

• Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master

  March 4, 2025

  Irvin Jackson

  A Special Master has issued a schedule for preparing the first Valsartan bellwether lawsuit for trial later this summer.

• FDA Removes Heart Attack, Stroke Warnings From Testosterone Drug Labels

  March 4, 2025

  Irvin Jackson

  Federal regulators are removing heart attack and stroke warnings from testosterone treatments following new studies that failed to find heart risks.

• Parties Propose Schedules for Second Wave of Valsartan Bellwether Lawsuits

  February 20, 2025

  Irvin Jackson

  Plaintiffs and defendants behind nearly 1,300 Valsartan cancer lawsuits have filed dueling schedules for a second wave of bellwether trials, with plaintiffs seeking to hold one multi-plaintiff trial.

• Preventing Preeclampsia in Women With Chronic Hypertension Lowers Death Risk: Study

  February 5, 2025

  Martha Garcia

  A new study reveals that, while women with chronic hypertension face an increased risk of preeclampsia, if the condition can be prevented their risk of maternal health problems was the same as other healthy women.

• Court Asked To Establish Valsartan Settlement Fund and Appoint Administrator

  January 23, 2025

  Irvin Jackson

  The judge presiding over the federal Valsartan lawsuits has been asked to approve the creation of a qualified settlement fund, as well as appoint an administrator and custodian for funds that will be paid to former users of the recalled hypertension drugs who have developed cancer.

• Five Valsartan Lawsuits Selected for Second Round of Bellwether Trials

  January 6, 2025

  Irvin Jackson

  A Special Master has ordered that five more Valsartan lawsuits be prepared for a second round of potential bellwether trials, to further test claims that the recalled blood pressure drugs caused users to develop cancer.

• Hypertension During Pregnancy Linked to Later Development of Neurological Disorders in Mothers: Study

  January 3, 2025

  Michael Adams

  Women diagnosed with hypertensive disorders during pregnancy have a greater risk of developing adult-onset neurological conditions years after they have given birth.